Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Clinical trial NCT02631746 · COMPLETED

Trial details

NCT number: NCT02631746
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Adult T-Cell Leukemia/Lymphoma Adult T-Cell Leukemia/Lymphoma Chronic Adult T-Cell Leukemia/Lymphoma HTLV-1 Infection Lymphomatous Adult T-Cell Leukemia/Lymphoma Smoldering Adult T-Cell Leukemia/Lymphoma

Start date: 2017-02-23
Primary completion: 2018-03-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.